Stay updated on PF-06463922 ALK/ROS1 Inhibitor Clinical Trial

Sign up to get notified when there's something new on the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 to the page history. Removed Revision: v3.4.3 from the history.
    Difference
    0.0%
    Check dated 2026-03-21T00:44:49.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Added revision: v3.4.3 and removed revision: v3.4.2 from the Record History.
    Difference
    0.0%
    Check dated 2026-03-06T18:36:24.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    New revision added: v3.4.2, replacing v3.4.1 in the history. No substantive page content changes are evident.
    Difference
    0.0%
    Check dated 2026-02-13T12:36:55.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    An additional revision entry v3.4.1 is added and the previous v3.4.0 entry is removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T14:24:18.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    The page history shows Revision: v3.3.4 in place of the previous v3.3.3. There are no visible changes to the study details or other user-facing content.
    Difference
    0.0%
    Check dated 2026-01-15T02:47:58.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    A new Revision: v3.3.3 was added; the HHS Vulnerability Disclosure link and Revision: v3.3.2 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-24T12:01:29.000Z thumbnail image

Stay in the know with updates to PF-06463922 ALK/ROS1 Inhibitor Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page.